浸性肝细胞癌与多重肺转移完全治愈使用nivolumab:一个病例报告
Ji Eun Han1, Hyo Jung Cho1, Soon Sun Kim1
1Department of Gastroenterology, Ajou University School of Medicine, Suwon, Korea.
Journal of liver cancer
|June 29, 2023
概括
尼沃卢马布作为先进的肝细胞癌 (HCC) 的救援疗法具有前景,这种癌症在氨酸激酶抑制剂 (TKI) 治疗后进展. 这种免疫检查点抑制剂 (ICI) 导致晚期HCC患者的瘤完全消失.
科学领域:
- 肝胆道癌症 肝胆道癌症
- 医学瘤学 医学瘤学
- 免疫治疗是一种免疫疗法.
背景情况:
- 目前治疗晚期肝细胞癌 (HCC) 的方法包括多激酶抑制剂 (氨酸激酶抑制剂,TKI) 和免疫检查点抑制剂 (ICI).
- 尼沃卢马布 (Nivolumab) 是一种ICI,已被批准用于高级HCC后索拉费尼布失败或不耐受症的二线治疗.
- 先进的HCC带来了重大治疗挑战,需要探索新的治疗策略.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


